US Stocks
/
IDEAYA Biosciences, Inc. Share Price

IDEAYA Biosciences, Inc. Share Price

NASDAQ: IDYA | Mid Cap
$36.12
+$0.01 (0.03%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

IDEAYA Biosciences, Inc. Stock Performance

Open
$36.05
Prev. Close
$36.11
Circuit Range
N/A
Day Range
$35.98 - $36.66
Year Range
$26.07 - $42.66
Volume
41,215
Average Traded
$36.22

IDEAYA Biosciences, Inc. Share Price Today

As of 10 October 2026, IDEAYA Biosciences, Inc.'s share price is $36.12. The stock opened at $36.05, compared to its previous close of $36.11. During today's trading session, IDEAYA Biosciences, Inc.'s share price traded between $35.98 and $36.66, with an average price of $36.32. Over the past 52 weeks, the stock has recorded a high of $42.66 and a low of $26.07. In terms of performance, IDEAYA Biosciences, Inc.'s share price has risen by 24.23% over the last six months and is up 13.34% on a year-on-year basis.

IDEAYA Biosciences, Inc. Share Price Chart

$35.98$36.66
L
Show Current Price
H

IDEAYA Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.20B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.81
Revenue (TTM)
$218.71B
Return On Equity (TTM)
-14.60%
Profit Margin
-51.99%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-194.31%

IDEAYA Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$207.83$10.88$6.56$8.86
Net Profit$119.24-$83.27-$98.54-$112.45
Net Profit Margin57.37%-765.35%-1502.13%-1269.19%
Income ChangeN/A-169.83%-18.34%-14.12%

IDEAYA Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$50.93$23.39$7.00$218.71
Net Profit-$58.66-$112.96-$274.48-$113.70
Net Profit Margin-115.18%-482.94%-3921.14%-51.99%
Income ChangeN/A-92.57%-142.99%58.58%

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

IDEAYA Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$38.35
$36.07
-6.34%
Sep 2026
$39.91
$38.51
-7.78%
Aug 2026
$35.13
$41.76
+17.70%
Jul 2026
$36.76
$35.48
-4.70%
Jun 2026
$29.61
$37.23
+26.37%
May 2026
$28.97
$29.46
+1.32%
Apr 2026
$33.53
$29.07
-12.70%
Mar 2026
$32.11
$33.30
+3.45%
Feb 2026
$32.40
$32.20
+0.00%
Jan 2026
$34.52
$32.20
-6.84%
Dec 2025
$35.36
$34.56
-2.95%
Nov 2025
$31.66
$35.61
+11.74%

IDYA Share Price FAQs

What is IDEAYA Biosciences, Inc. share price today?

chevron-up
IDEAYA Biosciences, Inc. share price today is $36.12 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of IDEAYA Biosciences, Inc. stock?

chevron-up
The 52 week high of IDEAYA Biosciences, Inc. stock is $42.66, while the 52 week low is $26.07 as of 10 Oct '26.

What is IDYA's market capitalisation today?

chevron-up
IDYA market capitalisation is $3.20B as of October 10, 2026, at 4:41 am IST.

What is IDYA's net income for the last quarter?

chevron-up
IDYA's net income for the last quarter is -112.45B USD.

What is the 5 year returns of IDYA?

chevron-up
The 5 year returns of IDYA is 68.47% as on 10 Oct '26.

What is the high & low stock price of IDYA today?

chevron-up
IDYA stock price hit a high of $36.66 and low of $35.98 as of 10 Oct '26.

Can I buy IDYA shares in India?

chevron-up
Yes. You can buy IDYA in India by opening an international trading account.